Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001337798-26-000002

Director acquired 2,799 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cole G Bradley Director 2026-05-29 Option exercise +2,799 15,345 D
Derivatives
Cole G Bradley Director 2026-05-29 Grant or award · Share Option +12,158 12,158 D
Cole G Bradley Director 2026-05-29 Grant or award · Restricted Share Units +2,026 2,026 D
Cole G Bradley Director 2026-05-29 Option exercise · Restricted Share Units −2,799 0 D
Loading xslF345X06/form4-06022026_080647.xml…